Search results
Home Phototherapy for Psoriasis: Optimizing Access
Medscape· 3 days agoSupporters of home phototherapy for patients with plaque and guttate psoriasis had plenty to cheer about at the annual meeting of the American Academy of...
Finding the Best Psoriasis Treatment: How I Got Psoriasis Relief
Verywell Health via Yahoo News· 4 days agoMy first psoriasis plaques (raised, inflamed, and scaly skin patches that can itch and be painful)...
At 44, Mindy Kaling Shares Her Diet and Fitness Routine Amid Weight Loss
Prevention via Yahoo News· 4 days agocampaign, an effort focused on empowering people living with moderate to severe plaque psoriasis...
Zai Lab doses first subject in Phase II plaque psoriasis treatment trial
Clinical Trials Arena via Yahoo Finance· 2 days agoZai Lab has dosed the first subject in a Phase II clinical trial of ZL-1102, an investigational...
Ultravate side effects: What they are and how to manage them
Healthline· 5 days agoUltravate (halobetasol propionate) is a prescription drug that’s used to treat plaque psoriasis. Ultravate can cause side effects that range from mild to ...
India's Sun Pharma beats Q4 profit view on strong US, domestic sales
Reuters via Yahoo Finance· 3 days agoSun Pharma's U.S. sales rose nearly 11.9% to 39.54 billion rupees, boosted by speciality complex...
J&J’s Tremfya meets endpoints in Phase III ulcerative colitis trial
Clinical Trials Arena via Yahoo Finance· 4 days ago(guselkumab) as a maintenance therapy in patients with moderate to severe active ulcerative colitis....
Robeco Institutional Asset Management B.V. Sells 180,219 Shares of Biogen Inc. (NASDAQ:BIIB)
ETF DAILY NEWS· 5 hours agoRobeco Institutional Asset Management B.V. trimmed its position in Biogen Inc. (NASDAQ:BIIB – Free Report) by 52.7% in the 4th quarter, according to its most recent 13F filing with the Securities ...
Teva and Alvotech Announce SIMLANDI® (adalimumab-ryvk) Injection Now Available in the U.S.
Morningstar· 5 days ago“We are proud to make SIMLANDI available in the U.S. to patients and providers,” said Thomas Rainey, Senior Vice President, U.S...
Swiss National Bank Cuts Stake in Protagonist Therapeutics, Inc. (NASDAQ:PTGX)
ETF DAILY NEWS· 8 hours agoSwiss National Bank trimmed its position in shares of Protagonist Therapeutics, Inc. (NASDAQ:PTGX – Free Report) by 9.8% in the 4th quarter, according to the company in its most recent Form ...